Corpus Intelligence IC Memo — BON SECOURS HOSPITAL 2026-04-26 06:39 UTC
IC Memo — BON SECOURS HOSPITAL
Investment Committee Memorandum | MD | 69 beds | Grade D | EBITDA uplift $1.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BON SECOURS HOSPITAL

CCN 210013 | BALTIMORE CITY, MD | 69 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

BON SECOURS HOSPITAL is a 69-bed community hospital in BALTIMORE CITY, MD with $18.8M in net patient revenue and a -38.5% operating margin. The hospital serves a payer mix of 0.0% Medicare, 0.0% Medicaid, and 100.0% commercial.

Thesis: Turnaround. Our ML models identify $1.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -38.5% to -31.1% (+736bps).

Net Revenue HCRIS$18.8M
Current EBITDA COMPUTED$-7.2M
Operating Margin COMPUTED-38.5%
Occupancy HCRISnan%
Revenue / Bed COMPUTED$273K
Net-to-Gross HCRIS52.1%
Distress Probability MLnan%

2. Market Context & Competitive Position

59
MD Hospitals
-8.3%
State Median Margin
18
Comparable Hospitals

MD has 59 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of -38.5% places it below the state median. Among 18 size-comparable peers (34-138 beds), the median margin is -1.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (34-138), prioritizing same-state peers. 18 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BON SECOURS HOSPITAL (Target)MD69$18.8M-38.5%
KENNEDY KRIEGERMD50$203.5M-50.0%
ST. MARYS HOSPITALMD105$198.5M-1.5%
UNION HOSPITAL OF CECIL COUNTYMD124$184.1M-4.6%
MEDSTAR MONTGOMERY MEDICAL CENMD96$173.7M-14.1%
CIVISTA MEDICAL CENTERMD98$154.9M2.9%
CALVERT MEMORIAL HOSPITALMD78$150.0M-7.2%
ATLANTIC GENERAL HOSPITALMD62$148.6M-12.0%
HOLY CROSS GERMANTOWN HOSPITALMD78$127.2M-29.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$395K+210bp18mo
Cost to Collect4.5%2.5%$376K+200bp12mo
Denial Rate Reduction12.0%6.5%$372K+198bp12mo
A/R Days Reduction5200.0%3800.0%$229K+122bp9mo
Clean Claim Rate88.0%96.0%$12K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$395K
Cost to Collect
$376K
Denial Rate Reduction
$372K
A/R Days Reduction
$229K
Clean Claim Rate
$12K
Total EBITDA Uplift$1.4M
Current EBITDA$-7.2M
+ RCM Uplift+$1.4M
Pro Forma EBITDA$-5.8M
Current Margin-38.5%
Pro Forma Margin-31.1%
WC Released (1x)$721K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-11.1M$-33.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-11.1M$-40.9M0.00x-100.0%
Bull Case9.0x11.0x$-10.0M$-39.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-10.0M$-46.5M0.00x-100.0%
Bear Case11.0x10.0x$-12.2M$-37.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-12.2M$-44.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 18 hospitals with 34-138 beds
  • Same-state prioritization (n=19)
  • Comp margins: P25=-10.8% / P50=-1.8% / P75=2.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.